FLT3-IN-15
FLT3-IN-15 is a highly potent and orally active FLT3 inhibitor with IC50s of 0.87 nM and 0.32 nM for FLT3 and FLT3/D835Y, respectively. FLT3-IN-15 can be used for researching acute myeloid leukemia[1].
Product Specifications
CAS Number
[2435562-99-3]
UNSPSC
12352005
Target
FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/flt3-in-15.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=C(/C1=C3NC4=CC=CC=C4C/3=N\OCCN5CCNCC5)C=C(C=C2)F.Cl
Molecular Formula
C22H23ClFN5O2
Molecular Weight
443.90
References & Citations
[1]Jeong P, Moon Y, Lee JH, et al. Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia. Eur J Med Chem. 2020;195:112205.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-494723 5 mg
3- (2,4-dimethoxyphenyl) -N- (2-ethoxyphenyl) -2- (2H-tetrazol-5-yl) propanamide
Ask
View Details 
GTR15099243 1 Vial
Lentiviral human DZIP1L shRNA (UAS) - Lentiviral human DZIP1L shRNA (UAS, iRFP) (100)
Ask
View Details C2405-03F 100 Tests
CD49f (Laminin Receptor, Integrin alpha6, VLA alpha6, Platelet gpIc) (FITC)
Ask
View Details